Real-time enrollment status for this clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:03 PM UTC
| NCT Number | NCT07195734 |
| Recruiting Status | Recruiting |
| Condition | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 |
| Phase | PHASE2 |
| Target Enrollment | 180 participants |
| Active Locations | 113 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 6, 2026 (6 days ago) |
As of October 12, 2026: Clinical trial NCT07195734 is currently recruiting participants. This phase2 study for clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 is actively seeking new participants at 113 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07195734 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 113 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07195734 was last updated 6 days ago (October 6, 2026). HelloStudys verifies this status automatically.